Literature DB >> 19076226

Identification of high- and low-virulent strains of Chlamydia pneumoniae by their characterization in a mouse pneumonia model.

Kirsten Sommer1, Florence Njau, Ulrike Wittkop, Jessica Thalmann, Gerda Bartling, Annette Wagner, Andreas Klos.   

Abstract

Contradicting reports exist about the pathogenicity of Chlamydia pneumoniae and the severity of the respiratory disease they cause. This study aimed to clarify, in mice, our hypothesis that marked differences in virulence of well-defined C. pneumoniae strains might exist for lung infections. C57BL/6J mice were intranasally infected with equal amounts of five different, identically prepared laboratory strains of C. pneumoniae. Based on the clinical score, weight, histopathological score, the granulocyte marker-enzyme myeloperoxidase, and the amount of Chlamydiae in the lung tissue, the C. pneumoniae isolates exhibited clear differences in overall growth characteristics or clearance, and pathological potential. Thus, we could identify chlamydial strains (Kajaani-K6 and CWL-029), where mice became seriously ill, as well as a relatively low-virulent isolate (TWAR-183). Cytokine profiles also varied drastically between the five strains in extent and kinetic. Our results indicate that C. pneumoniae isolates differ markedly with regard to their interaction with the host and their pathological potential. This might also be true for the infection in humans. Because the genomic diversity of C. pneumoniae is rather small, more subtle genomic deviations account most likely for the apparent functional differences. Our results will be useful to identify additional virulence factors in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076226     DOI: 10.1111/j.1574-695X.2008.00503.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  11 in total

1.  Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Carmine Tamborino; Silva Seraceni; Maria Rosaria Tola; Enrico Granieri; Carlo Contini
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

2.  Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice.

Authors:  Pavel Dutow; Sandra Lingner; Robert Laudeley; Silke Glage; Heinz-Gerd Hoymann; Anna-Maria Dittrich; Beate Fehlhaber; Meike Müller; Armin Braun; Andreas Klos
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

3.  The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response.

Authors:  Pavel Dutow; Beate Fehlhaber; Jenny Bode; Robert Laudeley; Claudia Rheinheimer; Silke Glage; Rick A Wetsel; Oliver Pabst; Andreas Klos
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

4.  Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells.

Authors:  Weidong Zhang; Xueqin Cao; Dongqing Chen; Jia-Wang Wang; Hong Yang; Wenshi Wang; Subhra Mohapatra; Gary Hellermann; Xiaoyuan Kong; Richard F Lockey; Shyam S Mohapatra
Journal:  Genet Vaccines Ther       Date:  2011-01-10

5.  Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells.

Authors:  Baishakhi Datta; Florence Njau; Jessica Thalmann; Hermann Haller; Annette D Wagner
Journal:  BMC Microbiol       Date:  2014-08-14       Impact factor: 3.605

6.  Complement and Chlamydia psittaci: Early Complement-Dependent Events Are Important for DC Migration and Protection During Mouse Lung Infection.

Authors:  Martin Kohn; Christian Lanfermann; Robert Laudeley; Silke Glage; Claudia Rheinheimer; Andreas Klos
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

7.  Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis: In Vivo Evaluation in Mice.

Authors:  Christian Lanfermann; Sebastian Wintgens; Thomas Ebensen; Martin Kohn; Robert Laudeley; Kai Schulze; Claudia Rheinheimer; Johannes H Hegemann; Carlos Alberto Guzmán; Andreas Klos
Journal:  Vaccines (Basel)       Date:  2021-06-06

8.  A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.

Authors:  Jenny Bode; Pavel Dutow; Kirsten Sommer; Katrin Janik; Silke Glage; Burkhard Tümmler; Antje Munder; Robert Laudeley; Konrad W Sachse; Andreas Klos
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

9.  Human blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae.

Authors:  Tanja Buchacher; Herbert Wiesinger-Mayr; Klemens Vierlinger; Beate M Rüger; Gerold Stanek; Michael B Fischer; Viktoria Weber
Journal:  BMC Immunol       Date:  2014-12-09       Impact factor: 3.615

10.  M2 Polarization of Human Macrophages Favors Survival of the Intracellular Pathogen Chlamydia pneumoniae.

Authors:  Tanja Buchacher; Anna Ohradanova-Repic; Hannes Stockinger; Michael B Fischer; Viktoria Weber
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.